Atlas Trials

Mesoblast, Ltd.

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Mesoblast, Ltd.

RecordFirmDate
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease (NCT07568535)Mesoblast, Ltd.2026-08-31
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain (NCT06325566)Mesoblast, Ltd.2024-07-03

Track Mesoblast, Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.